Needham & Company LLC Reiterates “Hold” Rating for agilon health (NYSE:AGL)

agilon health (NYSE:AGL)‘s stock had its “hold” rating reiterated by Needham & Company LLC in a note issued to investors on Wednesday,Benzinga reports.

Several other analysts have also issued reports on the stock. Macquarie initiated coverage on shares of agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and upped their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. TD Cowen reduced their price target on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Finally, Sanford C. Bernstein raised their price objective on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $3.95.

agilon health Trading Down 0.4 %

Shares of agilon health stock opened at $3.35 on Wednesday. The stock has a market cap of $1.38 billion, a P/E ratio of -3.56 and a beta of 0.66. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73. The business’s 50 day moving average is $2.94 and its 200-day moving average is $3.04.

Insider Buying and Selling at agilon health

In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The shares were acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the purchase, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John William Wulf purchased 45,000 shares of the stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 77,500 shares of company stock valued at $169,600 in the last ninety days. 3.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On agilon health

Several institutional investors have recently made changes to their positions in the stock. Capital International Investors increased its stake in agilon health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after acquiring an additional 9,346,295 shares during the period. Millennium Management LLC lifted its position in shares of agilon health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after acquiring an additional 4,706,357 shares during the period. Citigroup Inc. grew its holdings in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares in the last quarter. Algert Global LLC increased its position in shares of agilon health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after purchasing an additional 1,924,157 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in agilon health by 49.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after purchasing an additional 1,498,524 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.